Suche Orphan Drug
Weitere Suchoptionen
114 Ergebnis(se)
Wirkstoff(e)
- (2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid
- (4R,5R)-1-[[4-[[4-[3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxid-1-benzothiepin-5-yl]phenoxy]methyl]phenyl]methyl]-4-aza-1-azoniabicyclo[2.2.2]octan-chlorid
- (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
- (S)-3-(1-(9H-Purin-6-ylamino)Ethyl)-8-Chlor-2-Phenylisochinolin-1(2H)-on
- 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
- 17-(allylamino)-17-demethoxygeldanamycin, hydroquinone, hydrochloride
- 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine
- 5-{(1R,2R)-2-[(cyclopropylmethyl)amino]cyclopropyl}-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide monohydrochloride
- 68Ga-DOTA-pABzA-DIG-dPhe-Gln-Trp-Ala-Val-Gly-His-NHCHCH2-CHCH322
- A live attenuated bioengineered Listeria monocytogenes cancer immunotherapy
- A novel synthetic small molecule inhibitor designed to target TEAD
- Alisertib
- Alisitol, retinol palmitate, zinc gluconate
- Allogeneic cultured postnatal thymus-derived tissue
- Amatuximab
- Amnion-derived Cellular Cytokine Solution
- Apraglutide
- Autologe dendritische Zellen, die mit allogenem Tumorzelllysat behandelt wurden
- Autologe hämatopoetische Zellen, genetisch modifiziert mit einem lentiviralen-Vektor, der das humane gp91(phox) Gen enthält
- Autologous CD34+ cells transduced with a lentiviral vector encoding the human NCF1 gene
- Autologous CD34+ cells transduced with retroviral vector containing the human gp91 (phox) gene
- Autologous T cells genetically engineered to express an anti-mesothelin killer immunoglobulin-like receptor-chimeric antigen receptor (KIR-CAR)
- Belinostat
- Bevacizumab
- Bifidobacterium bifidum und Lactobacillus acidophilus
- Cannabidiol
- Celecoxib
- Crofelemer
- Darinaparsin
- Eflornithin
- Eflornithin
- Eflornithin in Kombination mit Sulindac
- Eicosapentaensäure
- Fenretinide
- Gegen humanes CD30-Antigen gerichteter, kovalent an die zytotoxische Substanz Monomethylauristatin E gebundener monoklonaler Antikörper
- Genetisch modifiziertes Adenovirus vom Serotyp 5/3, das für den Granulozyten-Makrophagen koloniestimulierenden Faktor kodiert
- Glutamine
- Heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148
- Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment
- Ilixadencel
- Imatinib mesilate
- Inhibitor of primary and secondary KIT and PDGFR alpha kinase mutants found in GIST
- Insulin human
- Interferon gamma-1A
- Interferon gamma-1B
- Lactobacillus reuteri
- Ligand binding moiety to STAT3, a chemical linker, and a ligand binding moiety to an E3 ligase that leads to STAT3 degradation
- Lithium carbonate
- Lurbinectedin
- Melatonin
- Mogamulizumab
- N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide
- N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
- Nanatinostat, valganciclovir
- Nilotinib
- Olverembatinib
- Oxalobacter formigenes Stamm HC-1
- Patupilon
- Pegylated recombinant arginine deiminase
- Poly-CD-PEG-camptothecin
- Ponatinib
- Pralatrexat
- Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein
- Regorafenib
- Rekombinantes humanes Parathormon
- Retifanlimab
- Romidepsin
- Setmelanotide
- Small Molecule Inhibitor of Exon 17 mutant KIT
- Small-molecule oral KIT inhibitor targeting activating mutations and resistance mutations
- Sunitinib
- T-Cell Depleted Stem Cell Enriched Cellular Product From Peripheal Blood Stem Cells
- Tazemetostat
- Teriparatide
- Thiostrepton
- Valproic acid, sodium
- Velusetrag
- Wilms' tumour 1 (WT1) vaccine
- Yttrium (90Y) Edotreotid
- Zanolimumab
- [4-(Methyl-1H-pyrazol-4-yl)-benzyl] -(6-[7-(3-pyrrolidin-1-yl-propoxy)-imidazo[1,2-a] pyridin-3-yl]-pyrimidin-4-yl]-amine
- [Ala1,3,12,Gln10,Arg11,Trp14]PTH(1-14)/[Ala18,22, Lys26]PTHrP(15-36)COOH
- [gly2] Recombinant human glucagon-like peptide
- doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31-aminoacid peptide targeting nucleolin